Latest News

Protecting R&D and Clinical Trial Data in the Age of AI

Protecting R&D and Clinical Trial Data in the Age of AI

Drug development is one of the most expensive and time-intensive innovation processes in the world. Estimates from the Tufts Center for the Study of Drug Development suggest that bringing a new drug to market can cost over $2.6 billion and take more than a decade of...

read more

Latest News

Medical Writers Become Strategic Partners

Medical Writers Become Strategic Partners

In regulated drug development, documentation shapes how a program is understood long before regulators ever see it. Protocols, investigator brochures, integrated summaries, and submission-ready modules establish the scientific and strategic narrative of a development...

read more
Weekly News Roundup | 16 March 2026

Weekly News Roundup | 16 March 2026

Your essential life science news digest: the past week's biggest stories in pharma, biotech and healthcare. 👇 This week's life science news was defined by regulatory uncertainty and clinical momentum. A landmark FDA leadership departure sent rare disease stocks...

read more

Join The Future Of Life Sciences Media

 

In a world overflowing with information, LifeScienceDaily.news stands apart as the dedicated space where life sciences professionals share what’s new, what’s next, and why it matters — all in real time.

 

 

Don’t wait for the media to pick up your story. Be the media.

More News

Reflections and Healing at the End of Life

Reflections and Healing at the End of Life

Words To Begin At age 81, the author has lived a "life of letters" (perhaps three million words) addressing a wide variety of subjects during multiple careers: Systems Engineering (PhD at UCLA in 1976), Military Science (21 years on active duty, in high-tech...

read more
The Microbiome: The Missing Layer in Modern Metabolic Care

The Microbiome: The Missing Layer in Modern Metabolic Care

Over the last decade, obesity management has undergone a structural transformation. What was once a field dominated almost exclusively by bariatric surgery has evolved into a far more nuanced metabolic discipline. The rise of GLP-1 receptor agonists and dual incretin...

read more
FDA Overhauls Pharmacokinetic Study Requirements

FDA Overhauls Pharmacokinetic Study Requirements

FDA Overhauls Pharmacokinetic Study Requirements in New Biosimilar Draft Guidance The US Food and Drug Administration (FDA) has overhauled biosimilar pharmacokinetic study requirements in new draft guidance issued on 9 March 2026, aimed at further reducing the time...

read more
Breakthroughs in the Lab – Blind Spots in Reality 

Breakthroughs in the Lab – Blind Spots in Reality 

Obesity care is at a turning point. GLP-1s like Ozempic and Mounjaro have upended weight loss culture – and the research backs them up. For the first time, multiple randomized trials have found that anti-obesity medications can lead to an average 15-20% weight loss....

read more
Reflections and Healing at the End of Life

Reflections and Healing at the End of Life

Words To Begin At age 81, the author has lived a "life of letters" (perhaps three million words) addressing a wide variety of subjects during multiple careers: Systems Engineering (PhD at UCLA in 1976), Military Science (21 years on active duty, in high-tech...

read more
The Microbiome: The Missing Layer in Modern Metabolic Care

The Microbiome: The Missing Layer in Modern Metabolic Care

Over the last decade, obesity management has undergone a structural transformation. What was once a field dominated almost exclusively by bariatric surgery has evolved into a far more nuanced metabolic discipline. The rise of GLP-1 receptor agonists and dual incretin...

read more
FDA Overhauls Pharmacokinetic Study Requirements

FDA Overhauls Pharmacokinetic Study Requirements

FDA Overhauls Pharmacokinetic Study Requirements in New Biosimilar Draft Guidance The US Food and Drug Administration (FDA) has overhauled biosimilar pharmacokinetic study requirements in new draft guidance issued on 9 March 2026, aimed at further reducing the time...

read more
Breakthroughs in the Lab – Blind Spots in Reality 

Breakthroughs in the Lab – Blind Spots in Reality 

Obesity care is at a turning point. GLP-1s like Ozempic and Mounjaro have upended weight loss culture – and the research backs them up. For the first time, multiple randomized trials have found that anti-obesity medications can lead to an average 15-20% weight loss....

read more

Featured Articles

Dr Louise Newson, hormone health expert and menopause specialist, discussing hormone tracking and women’s health

Why Hormone Tracking will be a Key Health Trend for 2026

Hormone health expert and bestselling author Dr Louise Newson explains why we'll all be tracking our hormones in 2026. The use of period tracking apps and menopause symptom tracker apps are at an all-time high. And it’s no wonder. These apps can be incredibly useful...

Life Science Daily News: Join the Community

A Community-Driven Hub for Life Sciences News and Discovery In an era of rapid scientific progress and near-constant breakthroughs, having a reliable, inclusive platform to share and explore life-sciences news is more important than ever. Life Science Daily News...
Researcher checking process data on modular bioprocess control hardware

Lego for Biotech Labs

How Modular Hardware Is Breaking Decades of Vendor Lock-In There’s a running joke among biotech lab managers that goes something like this: You don’t buy a bioreactor. You buy a relationship. A very expensive, very locked-in relationship. It’s funny because it’s...

Welcome to Life Science Daily News

Your Gateway to Discovery, Innovation, and Global Scientific Voices In a world where breakthroughs happen every day and scientific understanding is accelerating faster than ever before, Life Science Daily News stands as a vibrant hub for curious minds, passionate...

Further News

Why a New Era of Medical Innovation is Taking Shape

Why a New Era of Medical Innovation is Taking Shape

Over the next decade, modern medicine is poised to undergo a redefinition that has not been seen in generations. The surge in innovation, transformational scientific discoveries and rapidly maturing technologies is redefining patient outcomes. The biotech industry is...

read more
Summary: England Rare Diseases Action Plan 2026

Summary: England Rare Diseases Action Plan 2026

The England Rare Diseases Action Plan 2026 outlines how the Department of Health and Social Care and partner organisations are delivering commitments under the UK Rare Diseases Framework to improve outcomes for people living with rare conditions in England. The report...

read more

Further News

Thermo Fisher Scientific Opens New Distribution Center in Ireland

70,000 sq. ft. facility expands the company's biopharma, chemical and cold chain storage capacities DUBLIN, Ireland, (March 6, 2026) - Thermo Fisher Scientific Inc, the world leader in serving science, today announced the opening of a new, 70,000 sq.ft. distribution...

The Microbiome, as a Performance Regulator: Gut Integrity Under Physiological Load

In high-performance populations — elite athletes, tactical operators, founders, executives under sustained cognitive load — resilience is typically framed in terms of cardiovascular output, muscular strength, mitochondrial density or hormonal optimisation. Yet one of...

From Living Room to Lab: New Dementia Study to Close Participation Gap

People living with dementia will help close a long-standing weakness in research - the clinical trial evidence gap - in a new home-based study.  While those over 65 account for two-thirds of illness in the UK, they make up just one-third of trial participants. This...

Why a New Era of Medical Innovation is Taking Shape

Over the next decade, modern medicine is poised to undergo a redefinition that has not been seen in generations. The surge in innovation, transformational scientific discoveries and rapidly maturing technologies is redefining patient outcomes. The biotech industry is...

Activating Autophagy, Your Body’s Natural Metabolic Superpower

Did you know that your body has its own biological process for clearing out old or damaged cells, and recycling dysfunctional components to prioritize healthier, more productive ones? For billions of years, autophagy has acted as a kind of evolutionary survival...

Beyond the Basics: How Behavioral Intelligence and ML Reduce Trial Dropout

Medication non-adherence and dropout have long been labeled “known problems” in the clinical trial space. Yet despite years of tinkering with the formula, these challenges have only become “well-known problems.” Operational efficiencies and innovation, digital...

Why Health Platforms Built for Millennials Will Fail Gen Alpha

The first smartphone-native generation expects fundamentally different things from digital health and retrofitting won't work Gen Alpha (born roughly between 2010 and 2024) is the first generation to grow up entirely in a world where smartphones, AI assistants, and...

Summary: England Rare Diseases Action Plan 2026

The England Rare Diseases Action Plan 2026 outlines how the Department of Health and Social Care and partner organisations are delivering commitments under the UK Rare Diseases Framework to improve outcomes for people living with rare conditions in England. The report...

A Decentralized Advantage: Outpatient Theranostics is the Clinical Standard

While oncology has historically relied on a "Hospital-as-Hub" model, the specific logistical demands of radiopharmaceutical therapy (RPT) are revealing its limitations. The decentralized outpatient model is emerging as a significant industry trend, demonstrating that...

Why Patent Portfolios are Crucial for Life Science Innovators

In the life sciences sector, long-term success is dependent on more than innovation alone. To secure funding, enter strategic alliances, and achieve leadership in competitive markets, companies must protect their innovations by implementing a strategic intellectual...

The Convergence Era: How Data and AI are Reshaping Life Sciences

For decades, innovation in life sciences followed a familiar path: lab discovery, clinical testing, regulatory approval, market release. It was linear. Predictable. Slow. What’s happening now feels different. The most significant shift isn’t a single breakthrough...

Atomic Warriors: How Structural Biology is Decoding the Next Pandemic

As the echoes of the COVID-19 crisis fade, humanity remains on high alert for the inevitable next pathogen. What if we could dissect viruses down to their atomic core, revealing chinks in their armor that lead to revolutionary treatments? Drawing from my 12+ years as...

Want to Be Part of the Next Chapter in Life Sciences Media?

 

LifeScienceDaily.news is building a new kind of platform where innovators, researchers, and industry leaders tell their own stories and shape the narrative of what’s next in life sciences. Share your story and lead the conversation.

 

 

Don’t wait for the media to pick up your story. Be the media.

See More Articles

Want to Be Part of the Next Chapter in Life Sciences Media?

 

LifeScienceDaily.news is building a new kind of platform where innovators, researchers, and industry leaders tell their own stories and shape the narrative of what’s next in life sciences. Share your story and lead the conversation.

 

 

Don’t wait for the media to pick up your story. Be the media.